Cargando…
The disease formerly known as rheumatoid arthritis
Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Ther...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075245/ https://www.ncbi.nlm.nih.gov/pubmed/25167330 http://dx.doi.org/10.1186/ar4593 |
_version_ | 1782323312213360640 |
---|---|
author | Firestein, Gary S |
author_facet | Firestein, Gary S |
author_sort | Firestein, Gary S |
collection | PubMed |
description | Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Therefore, it might be appropriate to begin thinking about rheumatoid arthritis as a syndrome rather than a disease. Use of genetics, epigenetics, microbiomics, and other unbiased technologies will probably permit stratification of patients based on mechanisms of disease rather than by clinical phenotype. |
format | Online Article Text |
id | pubmed-4075245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40752452014-12-26 The disease formerly known as rheumatoid arthritis Firestein, Gary S Arthritis Res Ther Commentary Rheumatoid arthritis is a complex disease where predetermined and stochastic factors conspire to confer disease susceptibility. In light of the diverse responses to targeted therapies, rheumatoid arthritis might represent a final common clinical phenotype that reflects many pathogenic pathways. Therefore, it might be appropriate to begin thinking about rheumatoid arthritis as a syndrome rather than a disease. Use of genetics, epigenetics, microbiomics, and other unbiased technologies will probably permit stratification of patients based on mechanisms of disease rather than by clinical phenotype. BioMed Central 2014 2014-06-26 /pmc/articles/PMC4075245/ /pubmed/25167330 http://dx.doi.org/10.1186/ar4593 Text en Copyright © 2014 Firestein; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 The licensee has exclusive rights to distribute this article, in any medium, for 6 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Firestein, Gary S The disease formerly known as rheumatoid arthritis |
title | The disease formerly known as rheumatoid arthritis |
title_full | The disease formerly known as rheumatoid arthritis |
title_fullStr | The disease formerly known as rheumatoid arthritis |
title_full_unstemmed | The disease formerly known as rheumatoid arthritis |
title_short | The disease formerly known as rheumatoid arthritis |
title_sort | disease formerly known as rheumatoid arthritis |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075245/ https://www.ncbi.nlm.nih.gov/pubmed/25167330 http://dx.doi.org/10.1186/ar4593 |
work_keys_str_mv | AT firesteingarys thediseaseformerlyknownasrheumatoidarthritis AT firesteingarys diseaseformerlyknownasrheumatoidarthritis |